NASDAQ:INGN - Inogen Stock Price, Price Target & More

$138.49 -3.77 (-2.65 %)
(As of 04/25/2018 08:30 AM ET)
Previous Close$142.26
Today's Range$137.01 - $143.67
52-Week Range$80.04 - $144.31
Volume121,600 shs
Average Volume140,353 shs
Market Capitalization$3.02 billion
P/E Ratio110.28
Dividend YieldN/A

About Inogen (NASDAQ:INGN)

Inogen logoInogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

Receive INGN News and Ratings via Email

Sign-up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies


Debt-to-Equity RatioN/A
Current Ratio6.74%
Quick Ratio6.19%


Trailing P/E Ratio110.28
Forward P/E Ratio86.56
P/E Growth3.96

Sales & Book Value

Annual Sales$249.44 million
Price / Sales11.78
Cash Flow$1.9068 per share
Price / Cash72.63
Book Value$10.88 per share
Price / Book12.73


EPS (Most Recent Fiscal Year)$1.31
Net Income$21 million
Net Margins8.42%
Return on Equity13.47%
Return on Assets11.17%


Outstanding Shares21,210,000

How to Become a New Pot Stock Millionaire

Inogen (NASDAQ:INGN) Frequently Asked Questions

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

How were Inogen's earnings last quarter?

Inogen (NASDAQ:INGN) announced its quarterly earnings data on Tuesday, February, 27th. The medical technology company reported $0.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.21 by $0.10. The medical technology company had revenue of $63.79 million for the quarter, compared to analyst estimates of $62.01 million. Inogen had a net margin of 8.42% and a return on equity of 13.47%. View Inogen's Earnings History.

When is Inogen's next earnings date?

Inogen is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for Inogen.

What price target have analysts set for INGN?

5 brokerages have issued 1 year price targets for Inogen's stock. Their forecasts range from $75.00 to $150.00. On average, they expect Inogen's stock price to reach $118.40 in the next twelve months. View Analyst Ratings for Inogen.

Who are some of Inogen's key competitors?

Who are Inogen's key executives?

Inogen's management team includes the folowing people:
  • Mr. Scott Wilkinson, CEO, Pres & Director (Age 53)
  • Mr. Brenton Taylor, Exec. VP of Engineering (Age 37)
  • Ms. Alison Perry Bauerlein, Exec. VP of Fin., CFO, Sec. & Treasurer (Age 37)
  • Mr. Matthew S. Scribner, Exec. VP of Operations (Age 51)
  • Mr. Byron Myers, Exec. VP of Sales & Marketing (Age 39)

Has Inogen been receiving favorable news coverage?

News stories about INGN stock have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Inogen earned a daily sentiment score of 0.07 on Accern's scale. They also assigned news stories about the medical technology company an impact score of 44.89 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Inogen?

Shares of INGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inogen's stock price today?

One share of INGN stock can currently be purchased for approximately $138.49.

How big of a company is Inogen?

Inogen has a market capitalization of $3.02 billion and generates $249.44 million in revenue each year. The medical technology company earns $21 million in net income (profit) each year or $1.31 on an earnings per share basis. Inogen employs 770 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]

MarketBeat Community Rating for Inogen (INGN)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  228 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  342
MarketBeat's community ratings are surveys of what our community members think about Inogen and other stocks. Vote "Outperform" if you believe INGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INGN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Inogen (NASDAQ:INGN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Inogen in the last 12 months. Their average twelve-month price target is $118.40, suggesting that the stock has a possible downside of 14.51%. The high price target for INGN is $150.00 and the low price target for INGN is $75.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.802.832.672.40
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $118.40$102.6667$98.50$90.80
Price Target Upside: 14.51% downside21.20% downside16.61% downside13.10% downside

Inogen (NASDAQ:INGN) Consensus Price Target History

Price Target History for Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/14/2018Piper JaffraySet Price TargetBuy$145.00LowView Rating Details
3/27/2018Needham & Company LLCReiterated RatingBuy$150.00HighView Rating Details
11/8/2017Leerink SwannReiterated RatingOutperform$115.00 -> $120.00N/AView Rating Details
6/26/2017JPMorgan ChaseBoost Price TargetOverweight$102.00LowView Rating Details
5/10/2017Stifel NicolausBoost Price TargetHold -> Hold$65.00 -> $75.00HighView Rating Details
4/18/2017SidotiInitiated CoverageNeutral -> Neutral$79.00MediumView Rating Details
(Data available from 4/25/2016 forward)


Inogen (NASDAQ:INGN) Earnings History and Estimates Chart

Earnings by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) Earnings Estimates

2018 EPS Consensus Estimate: $1.55
2019 EPS Consensus Estimate: $1.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.27$0.29$0.28
Q2 20182$0.43$0.52$0.48
Q3 20182$0.41$0.49$0.45
Q4 20182$0.27$0.41$0.34
Q1 20192$0.32$0.33$0.33
Q2 20192$0.49$0.53$0.51
Q3 20192$0.47$0.53$0.50
Q4 20192$0.31$0.44$0.38

Inogen (NASDAQ INGN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$0.29N/AView Earnings Details
2/27/2018Q4 2017$0.21$0.31$62.01 million$63.79 millionViewN/AView Earnings Details
11/7/2017Q3 2017$0.29$0.33$63.55 million$69.00 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.28$0.38$59.99 million$64.10 millionViewListenView Earnings Details
5/9/2017Q1 2017$0.12$0.27$49.06 million$52.50 millionViewListenView Earnings Details
2/28/2017Q416$0.10$0.25$46.19 million$50.85 millionViewListenView Earnings Details
11/3/2016Q316$0.13$0.16$47.89 million$54.42 millionViewN/AView Earnings Details
8/4/2016Q216$0.20$0.25$52.44 million$54.57 millionViewN/AView Earnings Details
5/9/2016Q116$0.12$0.11$41.75 million$43.00 millionViewN/AView Earnings Details
3/14/2016Q415$0.07$0.19$29.10 million$40.40 millionViewN/AView Earnings Details
11/10/2015Q315$0.13$0.13$36.99 million$40.80 millionViewListenView Earnings Details
8/11/2015Q215$0.15$0.17$36.88 million$44.00 millionViewListenView Earnings Details
5/12/2015Q1$0.07$0.08$29.98 million$33.70 millionViewListenView Earnings Details
4/27/2015Q115$0.03$0.06$19.80 million$29.10 millionViewN/AView Earnings Details
11/11/2014Q3 2014$0.06$0.11$28.00 million$29.40 millionViewN/AView Earnings Details
8/12/2014Q214$0.07$0.11$23.93 million$30.40 millionViewN/AView Earnings Details
5/13/2014Q114$0.04$0.05$20.70 million$23.60 millionViewN/AView Earnings Details
3/27/2014Q4 13$0.02$0.89$18.71 million$19.76 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Inogen (NASDAQ:INGN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Inogen (NASDAQ INGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.29%
Institutional Ownership Percentage: 98.87%
Insider Trading History for Inogen (NASDAQ:INGN)
Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ INGN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2018Ray Benjamin M AndersonDirectorSell1,000$139.82$139,820.001,000View SEC Filing  
4/16/2018Matt ScribnerEVPSell2,500$139.79$349,475.008,374View SEC Filing  
3/15/2018Matt ScribnerEVPSell2,500$127.95$319,875.00View SEC Filing  
3/8/2018Alison BauerleinEVPSell15,911$124.48$1,980,601.2820,072View SEC Filing  
3/1/2018Heath LukatchDirectorSell2,500$119.15$297,875.002,500View SEC Filing  
2/26/2018Heather D RiderDirectorSell5,222$131.13$684,760.863,222View SEC Filing  
2/21/2018Brenton TaylorEVPSell5,000$130.76$653,800.0038,982View SEC Filing  
2/20/2018Alison BauerleinCFOSell3,192$125.41$400,308.728,808View SEC Filing  
2/16/2018Alison BauerleinCFOSell8,808$125.03$1,101,264.248,808View SEC Filing  
2/16/2018Brenton TaylorEVPSell5,000$125.06$625,300.0038,982View SEC Filing  
2/14/2018Alison BauerleinCFOSell9,737$120.05$1,168,926.859,737View SEC Filing  
2/14/2018Brenton TaylorEVPSell15,000$117.47$1,762,050.0038,982View SEC Filing  
2/12/2018Alison BauerleinEVPSell27,630$116.46$3,217,789.8011,718View SEC Filing  
2/9/2018Alison BauerleinCFOSell11,718$115.87$1,357,764.6611,718View SEC Filing  
1/16/2018Matt ScribnerEVPSell2,500$116.17$290,425.007,297View SEC Filing  
1/16/2018Raymond HuggenbergerDirectorSell13,000$116.19$1,510,470.0010,208View SEC Filing  
1/16/2018Scott WilkinsonInsiderSell30,651$115.75$3,547,853.2538,107View SEC Filing  
1/2/2018Ray Benjamin M AndersonDirectorSell1,000$119.06$119,060.001,000View SEC Filing  
12/15/2017Raymond HuggenbergerDirectorSell14,000$119.92$1,678,880.007,808View SEC Filing  
12/14/2017Matt ScribnerEVPSell2,500$120.34$300,850.007,297View SEC Filing  
12/11/2017Byron MyersEVPSell10,000$116.81$1,168,100.0048,600View SEC Filing  
12/1/2017Heath LukatchDirectorSell2,500$126.40$316,000.00View SEC Filing  
11/17/2017Byron MyersEVPSell35,000$116.77$4,086,950.0048,600View SEC Filing  
11/13/2017Matt ScribnerEVPSell2,500$112.35$280,875.00View SEC Filing  
10/16/2017Raymond HuggenbergerDirectorSell14,000$94.07$1,316,980.007,808View SEC Filing  
10/12/2017Matt ScribnerEVPSell2,500$93.88$234,700.00View SEC Filing  
10/10/2017Alison BauerleinEVPSell15,000$94.93$1,423,950.00View SEC Filing  
9/15/2017Raymond HuggenbergerDirectorSell14,000$102.30$1,432,200.007,808View SEC Filing  
9/11/2017Matt ScribnerEVPSell2,500$103.23$258,075.006,964View SEC Filing  
9/6/2017Heath LukatchDirectorSell2,500$97.44$243,600.002,500View SEC Filing  
8/18/2017Matt ScribnerEVPSell2,500$92.45$231,125.006,964View SEC Filing  
8/15/2017Raymond HuggenbergerDirectorSell14,000$91.67$1,283,380.007,808View SEC Filing  
8/10/2017Alison BauerleinEVPSell6,667$92.64$617,630.8815,000View SEC Filing  
7/18/2017Matt ScribnerEVPSell2,500$94.21$235,525.004,833View SEC Filing  
7/14/2017Raymond HuggenbergerDirectorSell14,000$92.96$1,301,440.007,808View SEC Filing  
6/16/2017Matt ScribnerEVPSell2,500$91.54$228,850.004,833View SEC Filing  
6/15/2017Raymond HuggenbergerDirectorSell15,300$90.88$1,390,464.007,808View SEC Filing  
6/2/2017Byron MyersEVPSell10,000$90.00$900,000.0045,185View SEC Filing  
6/1/2017Scott WilkinsonInsiderSell23,437$88.06$2,063,862.2254,088View SEC Filing  
5/30/2017Heath LukatchDirectorSell9,000$88.52$796,680.007,246View SEC Filing  
5/18/2017Ray Benjamin M AndersonDirectorSell4,445$81.05$360,267.254,445View SEC Filing  
5/10/2017Alison BauerleinEVPSell6,666$83.24$554,877.8425,758View SEC Filing  
4/24/2017Byron MyersEVPSell10,000$80.00$800,000.0045,185View SEC Filing  
4/17/2017Matt ScribnerEVPSell2,500$75.28$188,200.004,064View SEC Filing  
3/15/2017Matt ScribnerEVPSell2,500$73.85$184,625.004,833View SEC Filing  
2/28/2017Brenton TaylorEVPSell3,750$70.07$262,762.5031,851View SEC Filing  
1/17/2017Matt ScribnerEVPSell2,500$63.91$159,775.004,833View SEC Filing  
1/17/2017Raymond HuggenbergerCEOSell5,680$63.96$363,292.8012,488View SEC Filing  
1/10/2017Brenton TaylorEVPSell5,105$65.31$333,407.5531,851View SEC Filing  
1/3/2017Brenton TaylorEVPSell31,823$65.69$2,090,452.8763,674View SEC Filing  
12/15/2016Raymond HuggenbergerCEOSell8,000$65.59$524,720.0014,808View SEC Filing  
12/14/2016Matt ScribnerEVPSell2,500$65.13$162,825.004,833View SEC Filing  
12/1/2016Scott WilkinsonInsiderSell26,706$61.64$1,646,157.8466,050View SEC Filing  
11/14/2016Matt ScribnerEVPSell2,500$63.80$159,500.004,833View SEC Filing  
10/17/2016Raymond HuggenbergerCEOSell7,089$56.24$398,685.368,342View SEC Filing  
10/12/2016Matt ScribnerEVPSell4,551$59.45$270,556.956,884View SEC Filing  
9/19/2016Matt ScribnerEVPSell4,551$60.18$273,879.186,884View SEC Filing  
9/16/2016Byron MyersVPSell6,200$60.04$372,248.0041,385View SEC Filing  
9/9/2016Byron MyersVPSell3,800$60.07$228,266.0035,585View SEC Filing  
8/18/2016Matt ScribnerEVPSell2,320$56.39$130,824.804,653View SEC Filing  
8/15/2016Raymond HuggenbergerCEOSell20,747$57.48$1,192,537.5627,555View SEC Filing  
8/9/2016Byron MyersVPSell13,000$55.00$715,000.0035,185View SEC Filing  
7/18/2016Matt ScribnerEVPSell4,102$50.46$206,986.926,435View SEC Filing  
7/18/2016Raymond HuggenbergerCEOSell20,747$50.41$1,045,856.2727,555View SEC Filing  
6/16/2016Matt ScribnerEVPSell4,102$47.66$195,501.322,738View SEC Filing  
6/16/2016Raymond HuggenbergerCEOSell20,747$47.86$992,951.4227,555View SEC Filing  
5/16/2016Matt ScribnerEVPSell4,102$43.82$179,749.646,435View SEC Filing  
5/16/2016Raymond HuggenbergerCEOSell20,746$44.18$916,558.2827,554View SEC Filing  
4/15/2016Matt ScribnerEVPSell4,102$48.62$199,439.246,435View SEC Filing  
4/15/2016Raymond HuggenbergerCEOSell29,635$48.59$1,439,964.6525,210View SEC Filing  
4/13/2016Brenton TaylorEVPSell6,500$48.00$312,000.0031,851View SEC Filing  
4/6/2016Alison BauerleinCFOSell9,278$46.18$428,458.0438,332View SEC Filing  
3/31/2016Alison BauerleinCFOSell4,360$44.33$193,278.8048,332View SEC Filing  
2/16/2016Matt ScribnerEVPSell4,102$30.26$124,126.522,333View SEC Filing  
1/14/2016Matt ScribnerEVPSell4,102$34.73$142,462.462,333View SEC Filing  
12/14/2015Matt ScribnerEVPSell4,102$40.40$165,720.802,333View SEC Filing  
11/12/2015Matt ScribnerEVPSell4,102$44.52$182,621.042,333View SEC Filing  
10/26/2015Brenton TaylorEVPSell5,000$41.38$206,900.0043,351View SEC Filing  
10/21/2015Raymond HuggenbergerCEOSell57,418$43.06$2,472,419.086,808View SEC Filing  
10/12/2015Matt ScribnerEVPSell4,102$44.06$180,734.122,333View SEC Filing  
10/1/2015Alison BauerleinCFOSell10,185$47.94$488,268.9043,890View SEC Filing  
9/25/2015Brenton TaylorEVPSell3,333$53.48$178,248.8443,351View SEC Filing  
9/16/2015Byron MyersVPSell1,700$55.00$93,500.0036,332View SEC Filing  
9/15/2015Raymond HuggenbergerCEOSell57,416$53.58$3,076,349.286,808View SEC Filing  
9/14/2015Byron MyersVPSell7,950$55.23$439,078.5036,332View SEC Filing  
9/10/2015Matt ScribnerEVPSell4,102$53.30$218,636.604,666View SEC Filing  
9/1/2015Alison BauerleinCFOSell6,500$48.21$313,365.0049,075View SEC Filing  
8/26/2015Scott WilkinsonEVPSell6,666$45.42$302,769.72View SEC Filing  
8/25/2015Brenton TaylorEVPSell3,333$46.84$156,117.7246,684View SEC Filing  
8/25/2015Ray Benjamin M. AndersonDirectorSell5,658$46.36$262,304.884,896View SEC Filing  
5/28/2015Timothy PetersenDirectorSell337,081$37.44$12,620,312.64View SEC Filing  
5/26/2015Timothy PetersenDirectorSell54,258$37.05$2,010,258.90View SEC Filing  
5/22/2015Timothy PetersenDirectorSell86,889$37.09$3,222,713.01View SEC Filing  
5/21/2015Timothy PetersenDirectorSell134,300$37.81$5,077,883.00View SEC Filing  
5/19/2015Timothy PetersenDirectorSell115,700$37.25$4,309,825.00View SEC Filing  
5/18/2015Timothy PetersenDirectorSell58,987$37.35$2,203,164.45View SEC Filing  
3/5/2015Matt ScribnerEVPSell4,102$33.69$138,196.38View SEC Filing  
2/25/2015Brenton TaylorEVPSell15,687$33.87$531,318.69View SEC Filing  
2/23/2015Alison BauerleinCFOSell15,687$33.10$519,239.70View SEC Filing  
2/19/2015Raymond HuggenbergerCEOSell25,722$33.95$873,261.90View SEC Filing  
2/13/2015Scott WilkinsonEVPSell18,333$32.87$602,605.71View SEC Filing  
2/5/2015Matt ScribnerEVPSell4,102$30.66$125,767.32View SEC Filing  
2/3/2015Timothy PetersenDirectorSell17,000$30.25$514,250.00View SEC Filing  
2/2/2015Timothy PetersenDirectorSell99,000$30.88$3,057,120.00View SEC Filing  
1/29/2015Timothy PetersenDirectorSell601,000$31.95$19,201,950.00View SEC Filing  
1/26/2015Brenton TaylorEVPSell15,687$31.53$494,611.11View SEC Filing  
1/23/2015Alison BauerleinCFOSell15,687$31.53$494,611.11View SEC Filing  
1/20/2015Raymond HuggenbergerCEOSell25,722$31.63$813,586.86View SEC Filing  
1/5/2015Matt ScribnerEVPSell4,102$31.14$127,736.28View SEC Filing  
1/5/2015Versant Ventures Ii LlcMajor ShareholderSell7,946$30.98$246,167.08View SEC Filing  
12/30/2014Scott WilkinsonEVPSell962$30.50$29,341.00View SEC Filing  
12/29/2014Scott WilkinsonEVPSell15,735$30.52$480,232.20View SEC Filing  
12/24/2014Byron MyersVPSell7,514$30.07$225,945.98View SEC Filing  
12/23/2014Alison BauerleinCFOSell15,687$29.85$468,256.95View SEC Filing  
12/23/2014Byron MyersVPSell3,018$30.04$90,660.72View SEC Filing  
12/23/2014Versant Ventures Ii LlcMajor ShareholderSell9,785$29.74$291,005.90View SEC Filing  
12/22/2014Byron MyersVPSell11,801$30.06$354,738.06View SEC Filing  
12/22/2014Scott WilkinsonEVPSell1,033$30.31$31,310.23View SEC Filing  
12/19/2014Raymond HuggenbergerCEOSell25,722$28.98$745,423.56View SEC Filing  
12/11/2014Scott WilkinsonEVPSell14,700$25.25$371,175.00View SEC Filing  
12/3/2014Matt ScribnerEVPSell4,102$24.09$98,817.18View SEC Filing  
11/25/2014Brenton TaylorEVPSell15,687$24.71$387,625.77View SEC Filing  
11/21/2014Alison BauerleinCFOSell15,687$24.49$384,174.63View SEC Filing  
11/19/2014Raymond HuggenbergerCEOSell25,722$24.25$623,758.50View SEC Filing  
11/19/2014Versant Ventures Ii LlcMajor ShareholderSell28,225$24.77$699,133.25View SEC Filing  
11/18/2014Scott WilkinsonEVPSell2,233$25.21$56,293.93View SEC Filing  
11/18/2014Versant Ventures Ii LlcMajor ShareholderSell11,848$24.83$294,185.84View SEC Filing  
11/17/2014Versant Ventures Ii LlcMajor ShareholderSell5,343$24.89$132,987.27View SEC Filing  
11/14/2014Heather D RiderDirectorBuy3,000$25.00$75,000.00View SEC Filing  
11/14/2014Scott WilkinsonEVPSell1,100$25.15$27,665.00View SEC Filing  
11/14/2014Versant Ventures Ii LlcMajor ShareholderSell9,433$25.13$237,051.29View SEC Filing  
11/10/2014Versant Ventures Ii LlcMajor ShareholderSell2,992$24.42$73,064.64View SEC Filing  
11/7/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$24.30$179,528.40View SEC Filing  
11/4/2014A/S NovoMajor ShareholderSell2,000,000$21.50$43,000,000.00View SEC Filing  
11/4/2014Raymond HuggenbergerCEOSell165,891$20.21$3,352,657.11View SEC Filing  
11/4/2014Timothy PetersenDirectorSell250,000$21.50$5,375,000.00View SEC Filing  
11/3/2014Matt ScribnerEVPSell4,102$24.08$98,776.16View SEC Filing  
10/29/2014Scott WilkinsonEVPSell18,333$22.41$410,842.53View SEC Filing  
10/27/2014Brenton TaylorEVPSell15,687$21.67$339,937.29View SEC Filing  
10/24/2014Versant Ventures Ii LlcMajor ShareholderSell4,647$20.76$96,471.72View SEC Filing  
10/23/2014Alison BauerleinCFOSell15,687$20.50$321,583.50View SEC Filing  
10/9/2014Versant Ventures Ii LlcMajor ShareholderSell1,900$20.83$39,577.00View SEC Filing  
10/8/2014Versant Ventures Ii LlcMajor ShareholderSell6,907$21.03$145,254.21View SEC Filing  
10/7/2014Timothy PetersenDirectorSell31,600$21.55$680,980.00View SEC Filing  
10/6/2014Timothy PetersenDirectorSell17,475$21.56$376,761.00View SEC Filing  
10/3/2014Timothy PetersenDirectorSell31,658$21.52$681,280.16View SEC Filing  
10/3/2014Ventures Lp Arboretum IIMajor ShareholderSell98,400$20.97$2,063,448.00View SEC Filing  
10/2/2014Timothy PetersenDirectorSell24,597$20.91$514,323.27View SEC Filing  
10/1/2014Matt ScribnerEVPSell8,204$20.25$166,131.00View SEC Filing  
10/1/2014Timothy PetersenDirectorSell42,145$20.61$868,608.45View SEC Filing  
9/30/2014Timothy PetersenDirectorSell84,500$20.23$1,709,435.00View SEC Filing  
9/24/2014Ventures Lp Arboretum IIMajor ShareholderSell83,500$20.34$1,698,390.00View SEC Filing  
9/23/2014Alison BauerleinCFOSell15,687$20.01$313,896.87View SEC Filing  
9/22/2014Raymond HuggenbergerCEOSell25,722$20.25$520,870.50View SEC Filing  
9/22/2014Timothy PetersenDirectorSell46,865$21.05$986,508.25View SEC Filing  
9/17/2014Timothy PetersenDirectorSell39,135$21.72$850,012.20View SEC Filing  
9/17/2014Ventures Lp Arboretum IIMajor ShareholderSell55,135$21.61$1,191,467.35View SEC Filing  
9/16/2014Timothy PetersenDirectorSell6,500$21.16$137,540.00View SEC Filing  
9/15/2014Byron MyersVPSell22,333$21.33$476,362.89View SEC Filing  
9/15/2014Scott WilkinsonEVPSell18,333$21.42$392,692.86View SEC Filing  
9/15/2014Timothy PetersenDirectorSell9,500$21.45$203,775.00View SEC Filing  
9/9/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$23.25$171,771.00View SEC Filing  
3/7/2014Charles E LarsenDirectorSell26,201$14.88$389,870.88View SEC Filing  
2/20/2014A/S NovoInsiderSell617,000$14.88$9,180,960.00View SEC Filing  
2/20/2014Loren L McfarlandDirectorBuy3,125$16.00$50,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Inogen (NASDAQ INGN) News Headlines

Inogen (INGN) Set to Announce Quarterly Earnings on MondayInogen (INGN) Set to Announce Quarterly Earnings on Monday - April 23 at 8:16 PM
Ray Benjamin M. Anderson Sells 1,000 Shares of Inogen (INGN) StockRay Benjamin M. Anderson Sells 1,000 Shares of Inogen (INGN) Stock - April 19 at 7:36 PM
Inogen to Announce First Quarter 2018 Financial Results on Monday, April 30, 2018Inogen to Announce First Quarter 2018 Financial Results on Monday, April 30, 2018 - April 19 at 4:55 PM
Head-To-Head Survey: Align Technology (ALGN) and Inogen (INGN)Head-To-Head Survey: Align Technology (ALGN) and Inogen (INGN) - April 18 at 11:08 PM
Form 4 Inogen Inc For: Apr 16 Filed by: Scribner MattForm 4 Inogen Inc For: Apr 16 Filed by: Scribner Matt - April 18 at 5:01 PM
Matt Scribner Sells 2,500 Shares of Inogen (INGN) StockMatt Scribner Sells 2,500 Shares of Inogen (INGN) Stock - April 17 at 10:33 PM
Inogen (INGN) Expected to Post Quarterly Sales of $62.60 MillionInogen (INGN) Expected to Post Quarterly Sales of $62.60 Million - April 17 at 2:32 AM
Invacare (IVC) & Inogen (INGN) Head-To-Head ContrastInvacare (IVC) & Inogen (INGN) Head-To-Head Contrast - April 15 at 7:19 PM
$0.27 EPS Expected for Inogen (INGN) This Quarter$0.27 EPS Expected for Inogen (INGN) This Quarter - April 15 at 7:18 PM
Piper Jaffray Reiterates $145.00 Price Target for Inogen (INGN)Piper Jaffray Reiterates $145.00 Price Target for Inogen (INGN) - April 15 at 8:35 AM
Inogen (INGN) Stock Rating Lowered by BidaskClubInogen (INGN) Stock Rating Lowered by BidaskClub - April 14 at 10:53 PM
Health Care Sector Update for 04/13/2018: CDNA,PLSE,IPCT,INGNHealth Care Sector Update for 04/13/2018: CDNA,PLSE,IPCT,INGN - April 13 at 4:47 PM
Oxygen device maker Inogen discloses customer data breachOxygen device maker Inogen discloses customer data breach - April 13 at 4:47 PM
Inogen discloses data breachInogen discloses data breach - April 13 at 9:23 AM
Medical device maker Inogen discloses data breachMedical device maker Inogen discloses data breach - April 13 at 9:23 AM
BRIEF-Inogen Discloses Data BreachBRIEF-Inogen Discloses Data Breach - April 13 at 9:23 AM
Inogen (INGN) Lowered to "Hold" at Zacks Investment ResearchInogen (INGN) Lowered to "Hold" at Zacks Investment Research - April 12 at 7:25 PM
Inogen (INGN) Upgraded to "Strong-Buy" at BidaskClubInogen (INGN) Upgraded to "Strong-Buy" at BidaskClub - April 12 at 6:15 PM
Inogen (INGN) Receives Consensus Recommendation of "Buy" from AnalystsInogen (INGN) Receives Consensus Recommendation of "Buy" from Analysts - April 12 at 9:07 AM
ValuEngine Upgrades Inogen (INGN) to BuyValuEngine Upgrades Inogen (INGN) to Buy - April 6 at 11:38 AM
Inogen (INGN) Raised to Strong-Buy at BidaskClubInogen (INGN) Raised to Strong-Buy at BidaskClub - April 6 at 11:07 AM
Validea Motley Fool Strategy Daily Upgrade Report - 4/3/2018Validea Motley Fool Strategy Daily Upgrade Report - 4/3/2018 - April 3 at 9:22 AM
Needham & Company LLC Raises Inogen (INGN) Price Target to $125.00Needham & Company LLC Raises Inogen (INGN) Price Target to $125.00 - April 1 at 11:24 AM
Zacks: Analysts Anticipate Inogen (INGN) Will Post Quarterly Sales of $62.60 MillionZacks: Analysts Anticipate Inogen (INGN) Will Post Quarterly Sales of $62.60 Million - March 31 at 1:56 AM
 Brokerages Expect Inogen (INGN) to Announce $0.27 EPS Brokerages Expect Inogen (INGN) to Announce $0.27 EPS - March 29 at 11:26 PM
Why Is Inogen (INGN) Down 7% Since its Last Earnings Report?Why Is Inogen (INGN) Down 7% Since its Last Earnings Report? - March 29 at 4:44 PM
Inogen (INGN) Downgraded to Hold at Zacks Investment ResearchInogen (INGN) Downgraded to Hold at Zacks Investment Research - March 29 at 12:19 PM
Inogen (INGN) Earns Buy Rating from Needham & Company LLCInogen (INGN) Earns Buy Rating from Needham & Company LLC - March 27 at 1:16 PM
Inogen Inc (INGN) EVP Sells $319,875.00 in StockInogen Inc (INGN) EVP Sells $319,875.00 in Stock - March 19 at 10:12 PM
Inogen Inc (INGN) Given Consensus Recommendation of "Buy" by BrokeragesInogen Inc (INGN) Given Consensus Recommendation of "Buy" by Brokerages - March 18 at 9:11 AM
Inogen Announces Participation in 17th Annual Needham Healthcare ConferenceInogen Announces Participation in 17th Annual Needham Healthcare Conference - March 14 at 6:08 PM
Zacks: Analysts Expect Inogen Inc (INGN) Will Post Quarterly Sales of $62.60 MillionZacks: Analysts Expect Inogen Inc (INGN) Will Post Quarterly Sales of $62.60 Million - March 14 at 2:54 AM
Contrasting Inogen (INGN) & Cardiovascular Systems (CSII)Contrasting Inogen (INGN) & Cardiovascular Systems (CSII) - March 12 at 1:44 PM
BidaskClub Upgrades Inogen (INGN) to BuyBidaskClub Upgrades Inogen (INGN) to Buy - March 10 at 6:00 PM
Alison Bauerlein Sells 15,911 Shares of Inogen Inc (INGN) StockAlison Bauerlein Sells 15,911 Shares of Inogen Inc (INGN) Stock - March 9 at 9:16 PM
WINTON GROUP Ltd Acquires Shares of 49,331 Inogen Inc (INGN)WINTON GROUP Ltd Acquires Shares of 49,331 Inogen Inc (INGN) - March 6 at 3:35 PM
Schwab Charles Investment Management Inc. Acquires 2,327 Shares of Inogen Inc (INGN)Schwab Charles Investment Management Inc. Acquires 2,327 Shares of Inogen Inc (INGN) - March 6 at 5:56 AM
Swiss National Bank Has $3.63 Million Position in Inogen Inc (INGN)Swiss National Bank Has $3.63 Million Position in Inogen Inc (INGN) - March 5 at 4:03 PM
Inogen Inc (INGN) Shares Sold by Wells Fargo & Company MNInogen Inc (INGN) Shares Sold by Wells Fargo & Company MN - March 5 at 3:11 PM
Inogen (INGN) Downgraded to "Hold" at Zacks Investment ResearchInogen (INGN) Downgraded to "Hold" at Zacks Investment Research - March 5 at 1:36 PM
19,102 Shares in Inogen Inc (INGN) Purchased by Bogle Investment Management L P DE19,102 Shares in Inogen Inc (INGN) Purchased by Bogle Investment Management L P DE - March 5 at 5:10 AM
Q1 2018 EPS Estimates for Inogen Inc (INGN) Lowered by AnalystQ1 2018 EPS Estimates for Inogen Inc (INGN) Lowered by Analyst - March 5 at 2:08 AM
OppenheimerFunds Inc. Has $22.31 Million Position in Inogen Inc (INGN)OppenheimerFunds Inc. Has $22.31 Million Position in Inogen Inc (INGN) - March 4 at 12:09 PM
Inogen (INGN) Downgraded to Hold at BidaskClubInogen (INGN) Downgraded to Hold at BidaskClub - March 3 at 11:10 PM
Next Century Growth Investors LLC Has $5.42 Million Holdings in Inogen Inc (INGN)Next Century Growth Investors LLC Has $5.42 Million Holdings in Inogen Inc (INGN) - March 3 at 3:55 PM
Inogen Inc (INGN) Position Raised by Arizona State Retirement SystemInogen Inc (INGN) Position Raised by Arizona State Retirement System - March 3 at 4:22 AM
Heath Lukatch Sells 2,500 Shares of Inogen Inc (INGN) StockHeath Lukatch Sells 2,500 Shares of Inogen Inc (INGN) Stock - March 2 at 6:56 PM
FY2021 EPS Estimates for Inogen Inc Increased by Analyst (INGN)FY2021 EPS Estimates for Inogen Inc Increased by Analyst (INGN) - March 2 at 5:31 PM
William Blair Analysts Raise Earnings Estimates for Inogen Inc (INGN)William Blair Analysts Raise Earnings Estimates for Inogen Inc (INGN) - March 2 at 9:04 AM
Q2 2018 EPS Estimates for Inogen Inc (INGN) Boosted by William BlairQ2 2018 EPS Estimates for Inogen Inc (INGN) Boosted by William Blair - March 1 at 9:20 AM

SEC Filings

Inogen (NASDAQ:INGN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Inogen (NASDAQ:INGN) Income Statement, Balance Sheet and Cash Flow Statement


Inogen (NASDAQ INGN) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.